Use of enzyme linked immunospot assay (ELISpot) for monitoring treatment response of pulmonary tuberculosis patients

Background Tuberculosis (TB) remains one of the major causes of death from a single infectious agent worldwide. The rapid emergence of drug resistant mycobacteria has strengthened the demand for rapid methods for detection of mycobacteria in clinical samples. As prevention of tuberculosis relies on...

Full description

Bibliographic Details
Main Authors: Ramadan M. Nafae, Mohammad A. Mohammad, Mohammad S. El-Gammal, Mohammad A.M. Abdullah
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2013-07-01
Series:Egyptian Journal of Chest Disease and Tuberculosis
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0422763813001118